SCRSF ScreenPro Security Inc. (PNK) at $0.002 on Mar 2026: oversold bounce setup
The most important fact: SCRSF stock is trading at $0.002 on the PNK exchange on 05 Mar 2026 with a volume spike of 150,404 shares, more than twice average volume. This immediate volume pickup supports an oversold bounce setup for ScreenPro Security Inc. that traders watch during market hours. We outline why the move is notable, the company’s key ratios, and a concise trade plan calibrated to liquidity and valuation risks for short-term and 12-month horizons.
Market snapshot: price, volume and trigger for an oversold bounce
SCRSF stock opened at $0.002 and held that level through early market hours while trading 150,404 shares versus an average of 64,104, giving a relative volume of 2.35. The key trigger for a possible bounce is higher-than-normal buying at the intraday $0.002 level, combined with a year high of $0.00675 and a year low of $0.00090, which frames a wide mean-reversion range for short-term traders.
Fundamentals and valuation: what the numbers say about ScreenPro Security
ScreenPro Security Inc. (SCRSF) lists on PNK in the United States in the Healthcare sector and shows strained fundamentals that matter for an oversold-bounce approach. Reported EPS is -0.01 and reported PE is -0.20, market cap is roughly $600,348 and shares outstanding are 300,173,771. Price-to-sales is 1.83, EV-to-sales is 2.08, and price-to-free-cash-flow is 1.56, which reflect valuation interest but also negative profitability and a negative book value per share of -0.029.
Meyka AI grade and metric summary for SCRSF stock
Meyka AI rates SCRSF with a score out of 100: 67.47 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 comparison, sector and industry metrics, financial growth, key ratios, forecasts, analyst consensus and fundamental growth. The grade signals cautious interest for a speculative oversold bounce given small market cap and mixed cash-flow metrics.
Technical setup: oversold bounce criteria and execution signals
The technical case for an oversold bounce in SCRSF stock is narrow but measurable: price equals the 50-day average ($0.002) and sits near the 200-day average ($0.00194), while volume surge suggests short-covering or renewed buying. Classic entry is on confirmation candle above intraday resistance with stop under the recent intraday low. Note that standard momentum indicators are unreliable on sub-penny names, so risk control and tight sizing are essential.
Risks and liquidity constraints to weigh before trading SCRSF stock
Primary risks for an oversold-bounce trade include extreme volatility, low free float, and weak short-term liquidity: current ratio is 0.28, cash per share is 0.00042, and book value per share is negative. Regulatory or information gaps and OTC/PNK listing dynamics can widen spreads and increase slippage. Position size should account for potential rapid moves and limited exit liquidity.
Trade plan, price targets and sector context for an oversold bounce
A disciplined strategy: scale into a small pilot position on confirmed intraday strength above $0.002, set a protective stop near $0.0018, and consider profit targets at the recent swing high ($0.00675) and an intermediate target of $0.004. ScreenPro sits in Healthcare — Medical Diagnostics & Research — a sector with mixed performance, so align exits with overall sector moves and volume confirmation.
Final Thoughts
Key takeaways: SCRSF stock is an oversold-bounce candidate during market hours on 05 Mar 2026 because price sits at $0.002 with a relative volume spike of 2.35. Fundamentals are weak—EPS -0.01, PE -0.20, negative book value—so any bounce is speculative and requires tight risk control. Meyka AI’s forecast model projects a near-term model target of $0.004 (implied upside 100.00%) and a 12-month scenario target of $0.01 (implied upside 400.00%) versus the current price $0.002. Forecasts are model-based projections and not guarantees. Traders should size positions small, use a stop under the short-term support, and monitor volume and sector flows. For company info visit Justera Health and for data reference see the company profile on FinancialModelingPrep source. For a live quote and alerts see our internal page SCRSF on Meyka. Meyka AI provides this as AI-powered market analysis only; this is not investment advice.
FAQs
Is SCRSF stock a buy on this oversold bounce?
SCRSF stock shows an oversold-bounce setup but carries high risk due to low liquidity and negative fundamentals. Consider small position sizing, strict stops, and confirmation by rising volume before buying.
What are realistic short-term targets for SCRSF stock?
Short-term traders can target $0.004 as a conservative bounce target and $0.00675 (recent year high) as an aggressive target. Use stops under the intraday support to limit downside.
How does ScreenPro Security’s valuation affect the bounce trade?
Valuation metrics like P/S 1.83 and P/FCF 1.56 suggest value interest, but negative EPS and negative book value increase downside risk; treat any bounce as technical, not fundamental, until earnings improve.
Where can I track SCRSF stock and company filings?
Track SCRSF stock on PNK market feeds and the company website Justera Health. For financial snapshots use trusted data providers and our Meyka page for real-time signals.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)